Home
Industry Reports
Pharmaceuticals and Healthcare

Adult and Adolescent Vaccines Market to 2017 – Partnerships Increase as Licensing and Co-Development Account for 73% of all Deal-Making Activity in 2010

Published: Aug-2011 Report Code: GBIHC146MR Report Format: Electronic PDF

Description

Inquire Before Buying

GBI Research, the leading business intelligence provider, has released its latest research, “Adult and Adolescent Vaccines Market to 2017 – Partnerships Increase as Licensing and Co-Development Account for 73% of all Deal-Making Activity in 2010”, which provides insights into the global vaccines market, forecast until 2017. The report provides an in-depth analysis of five vaccines, which include pneumococcal, seasonal flu, human papillomavirus, hepatitis A and hepatitis B. The report also examines the immunization schedules for the covered vaccines. In addition, the report also includes insights into the vaccines R&D pipeline. The report is built using data and information sourced from proprietary databases, primary and secondary research, and in-house analysis by GBI Research’s team of industry experts. GBI Research’s analysis shows that the overall global vaccines market was valued at $28 billion in 2010. The market is expected to witness growth at a CAGR of 11.5% for the forecast period, and will reach $56.7 billion by 2017. The global market revenues are expected to increase due to the introduction of new molecules which are currently in the regulatory filing stage, and those in the later stages of development. The top pharmaceutical companies in the vaccines market are GlaxoSmithKline, Sanofi, Pfizer, Novartis AG., Merck & Co. Inc, and SP-MSD. Approximately 88% of the market is covered by these six companies.

Scope

Data and analysis on the global adult and adolescent vaccines market
Annualized market data for the adult and adolescent vaccines market from 2007 to 2017 for pneumococcal vaccines, human pappilomavirus vaccines, seasonal flu vaccines, hepatitis A vaccines and hepatitis B vaccines
Key drivers and restraints that have had a significant impact on the market
The competitive landscape of the global vaccines market
Key M&A activities, licensing agreements and co-development deals that took place in the vaccines market between 2009 and 2011.

Reasons to Buy

Align your product portfolio to the markets with high growth potential.
Develop market-entry and market expansion strategies by identifying the potential region and therapeutic segments poised for strong growth.
Devise a more tailored country strategy through the understanding of key drivers and barriers of the vaccines market.
Develop key strategic initiatives by understanding the key focus areas and leading companies.
Accelerate and strengthen your market position by identifying key companies for mergers, acquisitions and strategic partnerships.

Related Industry Reports

License Details

Single User License:

$3,500.00

Site License:

$7,000.00

Global License:

$10,500.00

Search Help
To run a quick Search on GBI Research site, enter the keywords for which you wish to search. By default, quick search will return documents which have at least any one of the words you have queried (an automatic "Or" search).

Detailed Functionality
• Higher relevance will be given to those documents where your search terms appear a greater number of times. Avoid using words such "and" or "or".

Phrase Searches
• You can search for a phrase by typing the keywords in quotation marks (""). For example, typing "Global Energy Efficient Lighting" will only return documents that contain this exact phrase.

Or Queries
• By default, search returns documents that include any of your search terms. There is no need to include or between terms. The order in which the terms are typed will affect the search results.

And Queries
• Adding and between two search terms means the search will return documents including both terms, whether they are listed together or not.


	Electronic PDF copy delivered via email. Report can be used by individual purchaser only.


	Electronic PDF copy delivered via email. Report can be shared by unlimited users within one corporate location, e.g. a regional office.


	Electronic PDF copy delivered via email. Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company.